Neuland Laboratories is currently trading at its upper circuit limit of Rs. 67.30, up by 3.20 points or 4.99% from its previous closing of Rs. 64.10 on the BSE.
The scrip opened at Rs. 67.00 and has touched a high and low of Rs. 67.30 and Rs. 66.90 respectively. So far 2316 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 118.16 on 15-Jun-2011 and a 52 week low of Rs. 58.78 on 18-Nov-2011.
Last one week high and low of the scrip stood at Rs. 73.45 and Rs. 64.10 respectively. The current market cap of the company is Rs. 51.45 crore.
The promoters holding in the company stood at 38.43% while Institutions and Non-Institutions held 1.83% and 59.73% respectively.
Neuland Laboratories has reported results for fourth quarter ended March 31, 2012.
On the standalone basis, the company has posted a rise of 108.96% in its net profit at Rs 5.83 crore for the quarter ended March 31, 2012 as compared to Rs 2.79 crore for the same quarter in the previous year. Total income has increased by 2.35% at Rs 113.04 crore for quarter under review as compared to Rs 110.45 crore for the quarter ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.65 |
Dr. Reddys Lab | 1209.00 |
Cipla | 1503.40 |
Lupin | 2107.30 |
Zydus Lifesciences | 964.95 |
View more.. |